Amiflamine
Source: Wikipedia, the free encyclopedia.
Chemical compound
 | |
| Clinical data | |
|---|---|
| Other names | (+)-4-(dimethylamino)-α,2-dimethylphenethylamine |
| Routes of administration | Oral |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Amiflamine (FLA-336) is a
stereoisomer.[2]
Amiflamine shows preference for inhibiting MAO-A in
affinity for the serotonin transporter over the norepinephrine and dopamine transporters, as transporter-mediated carriage is required for amiflamine to enter monoaminergic neurons.[6]
See also
- Reversible inhibitor of MAO-A(RIMA)
- Monoamine oxidase inhibitor (MAOI)
References
|
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRAs Tooltip Norepinephrine releasing agents |
| ||||||||||||||
SRAs Tooltip Serotonin releasing agents |
| ||||||||||||||
| Others |
| ||||||||||||||
See also: Serotonergics • Monoamine metabolism modulators • Monoamine neurotoxins | |||||||||||||||
| Phenethylamines |
|
|---|---|
| Amphetamines |
|
| Phentermines |
|
| Cathinones |
|
| Phenylisobutylamines | |
| Phenylalkylpyrrolidines | |
| Catecholamines (and close relatives) |
|
| Miscellaneous |
|